Table 7.
Duration of treatment with bisphosphonates for those patients with bone metastases/lesions who had treatment stopped, by malignancy type and by country: data from the detailed questionnaire
| Treatment duration (%) | Total (N = 947) | France (n = 220) | Germany (n = 329) | Italy (n = 167) | Spain (n = 155) | UK (n = 74) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ST | HM | ST | HM | ST | HM | ST | HM | ST | HM | ST | HM | |
| ≤6 months | 15 | 18 | 27 | 19 | 3 | 0 | 11 | 25 | 26 | 15 | 51 | 21 |
| 7–12 months | 18 | 21 | 18 | 29 | 12 | 0 | 14 | 11 | 36 | 25 | 37 | 34 |
| 13–24 months | 52 | 41 | 33 | 42 | 70 | 65 | 58 | 31 | 28 | 48 | 6 | 12 |
| >24 months | 14 | 17 | 20 | 5 | 15 | 35 | 18 | 30 | 10 | 11 | 4 | 33 |
| Unknown | 1 | 3 | 2 | 6 | 0 | 0 | 0 | 4 | 0 | 0 | 3 | 1 |